COMMUNIQUÉS West-GlobeNewswire

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
07/05/2026
Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated in Q2 2026 Cash, cash equivalents, and investments of $61.0 million as of March 31, 2026; runway into second quarter of 2027 Live [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
CONSHOHOCKEN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
07/05/2026
Reported positive results from aleniglipron Phase 2 ACCESS II study with up to 16.3% body weight loss, demonstrating highest efficacy among oral GLP-1RAs at the 44-week time point and potentially comparable efficacy to [...]
Nephros Announces Financial Results for Quarter Ended March 31, 2026
07/05/2026
First-Quarter Net Revenue Growth of 7% to $5.2 million; Core Programmatic Revenue Grew by 23% Year Over Year SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology [...]
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
07/05/2026
Jazz announced U.S. FDA acceptance with Priority Review of Supplemental Biologics License Application (sBLA) for zanidatamab in first-line HER2-positive unresectable locally advanced or metastatic gastroesophageal [...]
Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
07/05/2026
Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular sensitivity as measured by microperimetry. Laru-zova was generally well- [...]
Strengthening Mental Health and Psychosocial Support Preparedness in Emergencies
07/05/2026
Canadian Red Cross launches new program to support Canadians impacted by emergencies OTTAWA, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has announced the Strengthening Mental Health and [...]
Renforcement des services en santé mentale et bien-être en préparation aux situations d’urgence
07/05/2026
La Croix-Rouge canadienne lance un nouveau programme en soutien aux personnes touchées par une situation d’urgence au pays OTTAWA, Ontario, 07 mai 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne annonce le lancement [...]
INVIAH Launches Beta in Chicago: The Doctor Comes to You
07/05/2026
Co-founders Dr. Yevhen Pavelko and Natallia Panysh introduce a physician home-visit platform, powered by proprietary AI technology, that addresses systemic failures in U.S. healthcare access, bringing in-person medical [...]
Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance
07/05/2026
Proven, Hands-On Training Model Drives Consistency, Team Confidence, and Client Outcomes Across National Footprint ORLANDO, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science-backed [...]
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
07/05/2026
Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platform RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or [...]
The Helios Alliance Applauds Dr. Rahul Gupta's Appointment to Knoa Foundation Board of Trustees
07/05/2026
Leadership team member brings national expertise to oversight of pharmaceutical company emerging from Purdue Pharma settlement, advancing transparency and accountability in opioid abatement nationwide Mobile, ALABAMA, [...]
SK pharmteco collabore avec Axle Informatics et les Instituts nationaux de la santé afin de développer des programmes de thérapie génique pour les maladies rares
07/05/2026
RANCHO CORDOVA, Californie, 07 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé ce jour un partenariat stratégique avec Axle Informatics et les Instituts nationaux de la santé (NIH) en vue de promouvoir le [...]
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
07/05/2026
Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in both VAS pain and ODI function measures and no dose-limiting toxicity safety [...]
TOMI Environmental Solutions’ Binary Ionization Technology Approved in Additional European Union Countries
07/05/2026
FREDERICK, Md., May 07, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2026
07/05/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Boyce Thompson Institute names Dr. Natalie Hoffmann inaugural Jane Silverthorne Postdoctoral Fellow
07/05/2026
Ithaca, NY, May 07, 2026 (GLOBE NEWSWIRE) -- To uncover how the symbiosis between plants and fungi could improve sustainable agriculture, the Boyce Thompson Institute (BTI) has awarded its inaugural Jane Silverthorne [...]
RAMSAY SANTE : Unaudited interim results at end March 2026
07/05/2026
PRESS RELEASE Paris, 7 th May 2026 Unaudited interim results at end March 2026 Solid fundamentals driving revenue growth, with strengthened efficiency gains lifting operational profitability Public funding to mitigate [...]

Pages